Skip to main content
OpenTrials

Clinical trial condition

Pneumococcal Infection

Explore clinical trials studying Pneumococcal Infection. Study availability and eligibility vary by location and protocol.

26 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Pneumococcal Infection trial results

Recruiting

A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

NCT07300267

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Madera Family Medical Group ( Site 1004) Madera, California, United States
  • Acevedo Clinical Research Associates ( Site 1029) Miami, Florida, United States
  • University of South Florida-Department of Pediatrics ( Site 1002) Tampa, Florida, United States
  • Cotton O'Neil Research Center ( Site 1039) Topeka, Kansas, United States
View all 14 locations
View Trial Details
Completed

A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China

NCT01692886

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Jiangsu Province Guanyun County Center for Disease prevention and Control Guanyun County,, Jiangsu, China
  • Jiangsu Province Huaiyin District Center for Disease prevention and Control Huaian City,, Jiangsu, China
  • Jiangsu Province Hongze County Center for Disease prevention and Control Huaian City, Jiangsu, China
  • Jiangsu Province Lianshui County Center for Disease prevention and Control Lianshui County, Jiangsu, China
View Trial Details
Completed

A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)

NCT06177912

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Central Research Associates ( Site 0145) Birmingham, Alabama, United States
  • Velocity Clinical Research, Phoenix ( Site 0122) Phoenix, Arizona, United States
  • Madera Family Medical Group ( Site 0120) Madera, California, United States
  • Optumcare Colorado Springs, LLC ( Site 0113) Colorado Springs, Colorado, United States
View all 92 locations
View Trial Details
Completed

Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)

NCT05696080

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Aventiv Research ( Site 0022) Mesa, Arizona, United States
  • Indago Research & Health Center, Inc ( Site 0002) Hialeah, Florida, United States
  • Triple O Research Institute, P.A ( Site 0011) West Palm Beach, Florida, United States
  • SKY Integrative Medical Center/SKYCRNG ( Site 0012) Ridgeland, Mississippi, United States
View all 44 locations
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)

NCT05158140

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Carbon Health ( Site 0045) North Hollywood, California, United States
  • Valley Clinical Trials Inc. ( Site 0002) Northridge, California, United States
  • Center for Clinical Trials, LLC ( Site 0022) Paramount, California, United States
  • Artemis Institute for Clinical Research ( Site 0024) San Diego, California, United States
View all 46 locations
View Trial Details
Completed

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)

NCT05425732

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Central Research Associates ( Site 0067) Birmingham, Alabama, United States
  • Lenzmeier Family Medicine/CCT Research ( Site 0006) Glendale, Arizona, United States
  • Desert Clinical Research/ CCT Research ( Site 0040) Mesa, Arizona, United States
  • Foothills Research Center/ CCT Research ( Site 0021) Phoenix, Arizona, United States
View all 112 locations
View Trial Details

Related conditions